Study Suggests Beneficial Effects of Psilocybin Are Independent of 5-HT2A
Mice experienced antidepressant effects even with the receptor blocked.
Scientific Studies
Music is a ‘Hidden Therapist’ in Psilocybin Therapy
A look back at the therapeutic role of music in psilocybin therapy.
ICSS for Assessing the Abuse Potential of Psychedelics
LSD, mescaline, and psilocybin show little abuse potential using this rodent model.
Psychedelic vs. Hallucinogen-What’s in a Name?
Psychedelic is becoming more commonplace, while hallucinogen may be falling from favor.
The Pitfalls and Challenges of Psychedelic Medicine
Psychedelics present unique epistemological and ethical challenges.
The Structure-Activity Relationship of Psilocybin Analogs
Seventeen 4-acetoxy and 4-hydroxy substituted derivatives “have psilocybin-like pharmacological properties.”
Psychedelics Show Promise for Treating Dementia
“…this stands up to scientific rigor and is worthy of further exploration.”
New Toad Venom Compound Synthesized for Clinical Use: 5-MeO-DMT Succinate
Leading scientists continue to remove roadblocks by developing methods for synthesizing psychedelic compounds for further research.
Serotonin and the Mental Organs Hypothesis
The Mental Organs Hypothesis reconsiders the relationship between 5-HT2 receptors and the qualitative effects of psychedelics.
Researchers Synthesize Novel Compound, Tabernanthalog, a Non-Hallucinogenic Ibogaine Analog
This compound exhibits reduced cardiotoxicity, psychoplastogen characteristics, and potential therapeutic effects in animal models.